Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Shire plc SHPG NASDAQ

NASDAQ • Healthcare • Medical - Pharmaceuticals • USD

SharesGrow Score
76/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Shire plc (SHPG) is a Medical - Pharmaceuticals company in the Healthcare sector, currently trading at $179.20. It has a SharesGrow Score of 74/100, indicating a above average investment profile with 4 out of 7 criteria passed.

Financials: revenue is $15.2B, +39.1%/yr average growth. Net income is $4.3B, growing at +161%/yr. Net profit margin is 28.2% (strong). Gross margin is 69% (-14.7 pp trend).

Balance sheet: total debt is $19.5B against $36.2B equity (Debt-to-Equity (D/E) ratio 0.54, moderate). Current ratio is 0.97 (tight liquidity). Debt-to-assets is 28.8%. Total assets: $67.8B.

SharesGrow 7-Criteria breakdown: Value 85/100 (Pass), Growth 100/100 (Pass), Past 100/100 (Pass), Health 33/100 (Fail), Moat 51/100 (Partial), Future ?/100 (Fail), Income 85/100 (Pass).

SHPG SharesGrow Score Overview

76/100
SharesGrow Score
Strong investment profile
View full scorecard →
VALUE 85/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 51/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 85/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SHPG

✓
VALUE Pass
85/100
SHPG trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✓
GROWTH Pass
100/100
SHPG: +39.1%/yr revenue is, +161%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✓
PAST Pass
100/100
SHPG: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
✗
HEALTH Fail
33/100
Balance sheet SHPG: Debt-to-Equity (D/E) ratio 0.54 (moderate), Current ratio is 0.97 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
51/100
SHPG: Gross margin is 69% (-14.7 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 51/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✓
INCOME Pass
85/100
SHPG: Net profit margin is 28.2%. healthy (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range182.47-123.73
Avg Volume (30D)1.3M
Beta (1Y)0.90
Share Statistics
EPS (TTM)14.13
Shares Outstanding$302.17M
IPO Date1998-03-25
Financial Highlights & Ratios
Revenue (TTM)$15.16B
Gross Profit$10.46B
EBITDA$4.24B
Net Income$4.27B
Operating Income$3.41B
Total Cash$472.4M
Total Debt$19.54B
Net Debt$19.07B
Total Assets$67.76B
Price / Earnings (P/E)12.7
Analyst Forecast
Company Info
ExchangeNASDAQ
CurrencyUSD

Price Chart

Track all markets on TradingView
SHPG
Shire plc  ·  NASDAQ
Healthcare • Medical - Pharmaceuticals

People Also View

LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
 RHHBF
RHHBF
Roche Holding AG
$415.00
-0.84%
 RHHBY
RHHBY
Roche Holding AG
$50.99
-0.08%
 AZN
AZN
AstraZeneca PLC
$201.21
-1.55%
 NVS
NVS
Novartis AG
$152.08
-0.85%
 MRK
MRK
Merck & Co., Inc.
$117.90
-1.72%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message